Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-22

Clinical Trial Update: Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone [Phase 4]

View source ↗

Summary

Phase 4 trial assessing prevention of post-operative atrial fibrillation using a combination of CardiaMend and amiodarone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)
  • CardiaMend

Snippet

Sponsor: WakeMed Health and Hospitals | Conditions: Post Operative Atrial Fibrillation | Phase 4 | Status: COMPLETED